NCT07634900 Comparison of the Efficacy of Inferior Alveolar Nerve Block and Digital Anesthesia in Pulpectomy of Mandibular Permanent Molars in Children
| NCT ID | NCT07634900 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Inonu University |
| Condition | Pulpitis - Irreversible |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2026-04-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effectiveness of inferior alveolar nerve block (IANB) and computer-controlled digital anesthesia in achieving adequate anesthesia in pediatric patients presenting with acute dental pain and requiring emergency endodontic treatment of mandibular permanent molars. Achieving profound anesthesia in such cases can be challenging due to acute inflammation. Participants will be randomly assigned to receive either conventional IANB or digital anesthesia. Pain perception during the procedure will be assessed using validated pain scales. In addition, physiological parameters including heart rate and blood pressure will be recorded to evaluate the stress response associated with each anesthesia technique. Anesthesia success will be determined based on the absence of pain during treatment and the need for supplemental anesthesia. The findings of this study are expected to provide evidence-based guidance for selecting the most effective and comfortable anesthesia technique in pediatric dental patients.
Eligibility Criteria
Inclusion Criteria: * Children aged 6-14 years * Patients presenting with acute dental pain * Patients requiring emergency endodontic treatment in mandibular permanent molars * Cooperative patients who allowed clinical procedures * Patients whose parents/legal guardians provided informed consent Exclusion Criteria: * Patients with systemic diseases affecting pain perception * Patients with known allergy to local anesthetic agents * Patients who used analgesics within 12 hours before treatment * Patients with non-restorable teeth * Patients with a history of behavioral management problems preventing treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07634900 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 14 Years, studying Pulpitis - Irreversible. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07634900 currently recruiting?
Yes, NCT07634900 is actively recruiting participants. Contact the research team at nsnr_mdr@hotmail.com for enrollment information.
Where is the NCT07634900 trial being conducted?
This trial is being conducted at Malatya, Turkey (Türkiye).
Who is sponsoring the NCT07634900 clinical trial?
NCT07634900 is sponsored by Inonu University. The trial plans to enroll 128 participants.